Edwards Lifesciences Reiterates 2025 Guidance; 2026 Forecast Issued

MT Newswires Live12-04

Edwards Lifesciences (EW) said Thursday it continues to expect 2025 adjusted earnings of $2.56 to $2.62 per share.

Analysts polled by FactSet expect $2.59.

The company also reiterated its sales growth for the year at the high end of the 9%-to-10% range.

The company said it expects 2026 adjusted EPS of between $2.80 and $2.95.

Analysts surveyed by FactSet expect $2.87.

Edwards expects sales for the year to be in a range of $6.4 billion to $6.8 billion.

Analysts polled by FactSet expect $6.64 billion.

Shares of Edwards Lifesciences were 1.2% higher in recent trading.

Price: 84.21, Change: +0.22, Percent Change: +0.26

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2588838198?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-04 22:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2588838198","market":"hk","top_or_hot":-1,"title":"Edwards Lifesciences Reiterates 2025 Guidance; 2026 Forecast Issued","media":"MT Newswires Live","content":"<html><body><p> Edwards Lifesciences (EW) said Thursday it continues to expect 2025 adjusted earnings of $2.56 to $2.62 per share.</p><p>Analysts polled by FactSet expect $2.59.</p><p>The company also reiterated its sales growth for the year at the high end of the 9%-to-10% range.</p><p>The company said it expects 2026 adjusted EPS of between $2.80 and $2.95.</p><p>Analysts surveyed by FactSet expect $2.87.</p><p>Edwards expects sales for the year to be in a range of $6.4 billion to $6.8 billion.</p><p>Analysts polled by FactSet expect $6.64 billion.</p><p>Shares of Edwards Lifesciences were 1.2% higher in recent trading.</p><p>Price: 84.21, Change: +0.22, Percent Change: +0.26</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Edwards Lifesciences Reiterates 2025 Guidance; 2026 Forecast Issued</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEdwards Lifesciences Reiterates 2025 Guidance; 2026 Forecast Issued\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-12-04 22:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Edwards Lifesciences (EW) said Thursday it continues to expect 2025 adjusted earnings of $2.56 to $2.62 per share.</p><p>Analysts polled by FactSet expect $2.59.</p><p>The company also reiterated its sales growth for the year at the high end of the 9%-to-10% range.</p><p>The company said it expects 2026 adjusted EPS of between $2.80 and $2.95.</p><p>Analysts surveyed by FactSet expect $2.87.</p><p>Edwards expects sales for the year to be in a range of $6.4 billion to $6.8 billion.</p><p>Analysts polled by FactSet expect $6.64 billion.</p><p>Shares of Edwards Lifesciences were 1.2% higher in recent trading.</p><p>Price: 84.21, Change: +0.22, Percent Change: +0.26</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00BN0W2T93.GBP","symbol_name":"GUINNESS SUSTAINABLE GLOBAL EQUITY \"C\" (GBP) ACC","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2588838198","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2588838198","pubTimestamp":1764859601,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Edwards Lifesciences  said Thursday it continues to expect 2025 adjusted earnings of $2.56 to $2.62 per share.Analysts polled by FactSet expect $2.59.The company also reiterated its sales growth for the year at the high end of the 9%-to-10% range.The company said it expects 2026 adjusted EPS of between $2.80 and $2.95.Analysts surveyed by FactSet expect $2.87.Edwards expects sales for the year to be in a range of $6.4 billion to $6.8 billion.Analysts polled by FactSet expect $6.64 billion.Shares of Edwards Lifesciences were 1.2% higher in recent trading.Price: 84.21, Change: +0.22, Percent Change: +0.26","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IE00BN0W2T93.GBP":"GUINNESS SUSTAINABLE GLOBAL EQUITY \"C\" (GBP) ACC","IE00BFXG0V08.USD":"BNY MELLON GLOBAL LEADERS \"B\" (USD) ACC","BK4504":"桥水持仓","EW":"爱德华兹","LU0345774391.USD":"NINETY ONE GSF AMERICAN FRANCHISE \"A\" (USD) ACC","IE00BN0W2W23.USD":"GUINNESS SUSTAINABLE GLOBAL EQUITY \"C\" (USD) ACC","LU0345774631.USD":"NINETY ONE GSF AMERICAN FRANCHISE \"A\" (USD) INC","BK4588":"碎股","BK4585":"ETF&股票定投概念","BK4567":"ESG概念","IE00BN0W2V16.EUR":"GUINNESS SUSTAINABLE GLOBAL EQUITY \"C\" (EUR) ACC","IE00BYQQ9H92.USD":"BNY MELLON GLOBAL LEADERS \"A\" (USD) ACC","BK4082":"医疗保健设备"},"translate_title":"爱德华兹生命科学公司重申2025年指导；发布2026年预测","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EW":1.5},"content_text":"Edwards Lifesciences (EW) said Thursday it continues to expect 2025 adjusted earnings of $2.56 to $2.62 per share.Analysts polled by FactSet expect $2.59.The company also reiterated its sales growth for the year at the high end of the 9%-to-10% range.The company said it expects 2026 adjusted EPS of between $2.80 and $2.95.Analysts surveyed by FactSet expect $2.87.Edwards expects sales for the year to be in a range of $6.4 billion to $6.8 billion.Analysts polled by FactSet expect $6.64 billion.Shares of Edwards Lifesciences were 1.2% higher in recent trading.Price: 84.21, Change: +0.22, Percent Change: +0.26","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2588838198","isCrawlerRequest":true}